New Issue: Orbital Catastrophe Ahead? Read Now

New Ideas about the Way Autoimmune Diseases Start and How to Stop Them

Millions suffer from ailments such as type 1 diabetes and lupus, in which the body attacks itself

Shadow of human silhouette.

Hayley Wall

Join Our Community of Science Lovers!

Annie, my friend John's kid sister, got sick when she was 11. I wasn't much older so I didn't know how serious it was when John said her disease was called lupus. I didn't realize her own cells were attacking her, sometimes going after her kidneys, other times her lungs. I did know, because her brother told me, that her face got really swollen because she had to take lots of pills called steroids, which had side effects that meant she could get very sick from flus or colds that he and I shrugged off. At times Annie missed long periods of school. At times she hurt badly. As she grew, she worked in children's theater, which she adored, and in local politics. Annie never got past lupus, though. She died at age 49.

Too many stories end this way. Lupus is an autoimmune disease, in which the body's guardian immune system turns traitor and tries to destroy the organs it is meant to protect. There are about 80 of these disorders—some estimates are higher—and in the U.S., almost 25 million people suffer from them, according to the National Institutes of Health. The number appears to be rising. The illnesses range from the familiar, such as type 1 diabetes and lupus, to the obscure, such as Takayasu's arteritis (in which large blood vessels become dangerously inflamed).

This special report highlights new discoveries about these ailments, too often understudied given their terrible toll. Fresh ideas are emerging about the ways such disorders get started, ideas that run counter to a century of medical dogma. And researchers now have theories that could explain the awful gender imbalance in autoimmune disease—nearly 80 percent of patients are women. These advances are leading to more refined treatments, based on a more nuanced understanding of our immune systems. Progress is still slow, but the changes carry with them hopes of overwriting a past filled with ineffective therapies or drugs that could be worse than the diseases themselves.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


How I Was Betrayed from Within

One patient recounts her journey through a world of disabling symptoms, ineffective treatments and dismissive doctors

The Terrible Toll of 76 Autoimmune Diseases

This list shows how common each disorder is, which body parts are stricken, and the illnesses’ tendency to afflict women

In Autoimmune Disease, Organs May Lure the Immune System into an Attack

New evidence indicates that target cells may play a role in their own destruction

Why Nearly 80 Percent of Autoimmune Sufferers Are Female

The effects of sex hormones, X chromosomes and different gut microbes may be parts of the answer

Targeted Treatments for Autoimmune Disease Make Progress

By aiming at specific genes or cells, researchers can boost effectiveness and reduce side effects

Josh Fischman was formerly senior editor for special projects at Scientific American and covered medicine, biology and science policy. He has written and edited about science and health for Discover, ScienceEarth and U.S. News & World Report. Follow Fischman on Bluesky @jfischman.bsky.social

More by Josh Fischman
Scientific American Magazine Vol 325 Issue 3This article was published with the title “The Body Against Itself” in Scientific American Magazine Vol. 325 No. 3 (), p. 26
doi:10.1038/scientificamerican0921-26

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe